GHEUENS SARAH (Chief Medical Officer) sold 35.4% of their position (30K shares) of AGIOS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $914.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/6/2026ACC: 0001439222-26-000120
Officer· Chief Medical Officer
Since Sep 2021
-30K
Net shares
Net seller
$914.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
30K disposed
Non-Derivative Transactions1
Common stock
Direct
Shares
−30K
Price / share
$30.48
Trade value
$914.40K
% of position
35.4%
8/4/2026
84.64K→54.65K
Total
Net shares
−30K
Net value
-$914.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 8/4/2026 | S · Sale | −30K | $30.48 | $914.40K | 35.4% | 84.64K | 54.65K |
| Total | −30K | -$914.40K | ||||||
Derivative Transactions0
No derivative transactions reported